IMMUNOPRECISE ANTIBODIES LTD's ticker is IPA and the CUSIP is 45257F200. A total of 18 filers reported holding IMMUNOPRECISE ANTIBODIES LTD in Q1 2023. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,639 | -42.1% | 1,540 | 0.0% | 0.00% | – |
| Q2 2023 | $4,555 | -27.1% | 1,540 | -31.7% | 0.00% | – |
| Q1 2023 | $6,251 | -85.5% | 2,255 | -72.7% | 0.00% | – |
| Q4 2022 | $42,997 | +48.3% | 8,255 | +9.5% | 0.00% | – |
| Q3 2022 | $29,000 | 0.0% | 7,540 | 0.0% | 0.00% | – |
| Q2 2022 | $29,000 | -23.7% | 7,540 | 0.0% | 0.00% | – |
| Q1 2022 | $38,000 | -5.0% | 7,540 | 0.0% | 0.00% | – |
| Q4 2021 | $40,000 | – | 7,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 1,028,253 | $1,882 | 0.09% |
| Gradient Capital Advisors, LLC | 26,808 | $49,059 | 0.02% |
| WEST PACES ADVISORS INC. | 1,665 | $3,047 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 15,927 | $29,147 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,382 | $4,359 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 17,484 | $31,995 | 0.00% |
| CITIGROUP INC | 7 | $13 | 0.00% |
| MORGAN STANLEY | 533 | $975 | 0.00% |
| Rathbones Group PLC | 14,000 | $25,620 | 0.00% |